CardiaLen
CardiaLen develops and commercializes pain-free cardioversion therapies for atrial fibrillation.
Launch date
Employees
Market cap
-
Enterprise valuation
€62—93m (Dealroom.co estimates Oct 2018.)
Brooklyn Center Minnesota (HQ)
Authorizing premium user...